Detalhe da pesquisa
1.
Phosphoramidates of 2'-beta-D-arabinouridine (AraU) as phosphate prodrugs; design, synthesis, in vitro activity and metabolism.
Bioorg Med Chem
; 18(7): 2439-46, 2010 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20299228
2.
RARalpha-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia.
Proc Natl Acad Sci U S A
; 104(47): 18694-9, 2007 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18000064
3.
FUS expression alters the differentiation response to all-trans retinoic acid in NB4 and NB4R2 cells.
Br J Haematol
; 139(1): 94-7, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17854312
4.
Clinical implications of gene expression profiling of acute myeloid leukemia.
Curr Hematol Malig Rep
; 1(2): 114-21, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20425341
5.
The effects of lestaurtinib (CEP701) and PKC412 on primary AML blasts: the induction of cytotoxicity varies with dependence on FLT3 signaling in both FLT3-mutated and wild-type cases.
Blood
; 108(10): 3494-503, 2006 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16868253
6.
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia.
Blood
; 106(12): 3768-76, 2005 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16105978